MaxCyte, Inc (MXCT) Files up to $100M IPO
Tweet
Share
E-mailGet Alerts MXCT Hot Sheet
Join SI Premium – FREE
MaxCyte, Inc (NASDAQ: MXCT) has files an up to $100,000,000 IPO.
The company describes itself as: "We are a leading commercial cell engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization."
Cowen, Stifel and William Blair will serve as underwriters.
Create E-mail Alert Related Categories
Corporate News, IPOsRelated Entities
Stifel, William Blair, Cowen & Co, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
